Site Index:

NIDA Proteomics Center >  Investigators

Yale/NIDA Proteomics Center Project Investigators
Overall Theme: “Biomarkers of Addiction”
 

Name	Department	Institution	Website	Role/Project Title
Patrick Allen	Psychiatry	Yale U.		Regulation of dendritic spine composition as a basis for synaptic plasticity
James Bibb	Psychiatry	The University of Texas Southwestern Medical Center		Phosphoproteomic Studies of NMDA Receptor-Cdk5 Interactions
Thomas Biederer	Molecular Biophysics & Biochemistry	Yale U.		Identification and analysis of protein complexes mediating synapse formation
Pietro De Camilli	Cell Biology	Yale U.		Lipid metabolism in neuronal signaling and synaptic function
Ralph DiLeone	Psychiatry	Yale U.		Proteomic Analysis of Neuropeptide Signaling in The Nucleus Accumbens
Ronald Duman	Psychiatry, Pharmacology	Yale U.		Regulation of neurotrophic factors by psychotropic drugs
Paul Greengard	Molecular and Cellular Neuroscience	Rockefeller U.		A novel approach to the understanding the actions of drugs of abuse
Paul Lombroso	Child Study Center	Yale U.		Involvement of the Tyrosine phosphatase, STEP, in the Actions of Amphetamine
Angus Nairn	Psychiatry	Yale U.		Studies of the role of DARPP-16 and DARPP-21 in the actions of drugs of abuse
Marina Picciotto	Psychiatry, Pharmacology, Neurobiology	Yale U.		Proteomic analysis of nicotine’s effects following behaviors related to reinforcement, withdrawal, depression, learning and aging
Arthur Simen	Psychiatry	Yale U.		Proteomic Analysis of Differential Transcription Factor Binding to a Novel GABA Transporter Promoter Variant
Rajita Sinha	Psychiatry	Yale U.		Proteomic Analysis of Stress-Related States in Addictive Disorders
Stephen Strittmatter	Neurobiology, Neurology	Yale U.		Proteomic analysis of axon plasticity in the adult brain
Jane Taylor	Psychiatry	Yale U.		Molecular correlates of cognitive-motivational dysfunction in animal models of addiction
Zoran Zimolo	Psychiatry	Yale U.		Biomarkers in depression, schizophrenia and bipolar illness as risk factors for substance abuse
				Protein and lipid markers of glutamatergic modulation and its relationship to nicotine abuse in schizophrenia
				Protein markers of THC or ketamine administration and early and late withdrawal in healthy human subjects

Copyright © 2004 - 2006, Yale University, New Haven, Connecticut, USA. All rights reserved.
Comments or suggestions to Greg Blasko.

Last modified: 30-Aug-2006 (GB)